AbbVie Says 340B Program Defines 'Patient' Too Broadly
By Mark Payne · April 8, 2026, 8:52 PM EDT
Federally funded healthcare providers in the 340B Drug Pricing Program are using an "overly broad" interpretation of the word "patient" based on government guidelines, and it's leading to them abusing 340B...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login